QT
BBIO icon

Quantamental Technologies’s BridgeBio Pharma BBIO Stock Holding History

Quantamental Technologies’s Portfolio BBIO Stock Details BBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-12,326
Closed -$112K – 503
2022
Q2 		$112K Buy
12,326
+2,111
+21% +$17.7K 0.05% 377
2022
Q1 		$104K Buy
+10,215
New +$105K 0.06% 345

Other funds holding BBIO

KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
AIG
American International Group New York $609M AUM 23.67% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

Quantamental Technologies's BBIO Position: Q3 2022 in Review

Quantamental Technologies sold out of BridgeBio Pharma (BBIO) in Q3 2022, closing a stake of 12,326 shares — an estimated $112K sold.

Quantamental Technologies first reported a position in BBIO in Q1 2022 and held it in 2 quarters. The position peaked at $112K in Q2 2022. 181 funds tracked by Wall St. Rank hold BBIO as of Q3 2022.

  • Quantamental Technologies reported no remaining BridgeBio Pharma position as of Q3 2022 after selling out during the quarter.
  • Quantamental Technologies sold 12,326 BridgeBio Pharma shares in Q3 2022, an estimated $112K.
  • Quantamental Technologies first reported a position in BridgeBio Pharma in Q1 2022 and held it in 2 quarters.
  • Quantamental Technologies's BridgeBio Pharma position peaked at $112K in Q2 2022.
  • 181 funds tracked by Wall St. Rank held BridgeBio Pharma as of Q3 2022.

Based on Quantamental Technologies's 13F filing for Q3 2022, filed 14 Nov 2022.